News
Emma Weston joined the clinical trial after running out of treatment options. For two years, she's been cancer free.
Medical Device Network on MSN2d
New data from J&J’s bladder cancer drug-device trial strengthens support for NDAJohnson & Johnson (J&J) has reported more data supporting the efficacy of its intravesical drug release system TAR-200 in ...
Johnson & Johnson (JNJ) posts promising Phase 2b trial results for its chemotherapy releasing system TAR-200 in bladder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback